12/03/2024
4:21 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
7:22 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:07 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
6:24 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
9:56 AM | Amylyx Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
10/25/2024
4:38 PM | Amylyx Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
10/17/2024
8:12 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/02/2024
5:48 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
5:50 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
5:53 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
5:53 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
4:56 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:39 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:30 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:55 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4/A | |
09/05/2024
6:26 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
5:49 PM | Amylyx Pharmaceuticals (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
08/08/2024
6:09 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:14 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2024
6:09 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | Amylyx Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
06/21/2024
4:07 PM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:42 PM | Amylyx Pharmaceuticals (Issuer)
Quimi Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:44 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:49 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:50 PM | Amylyx Pharmaceuticals (Issuer)
Firestone Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:52 PM | Amylyx Pharmaceuticals (Issuer)
FONTEYNE PAUL R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:36 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:37 PM | Amylyx Pharmaceuticals (Issuer)
Quimi Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:05 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:12 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
6:12 AM | Amylyx Pharmaceuticals (Filer)
| Form DEFA14A | |
04/24/2024
6:19 AM | Amylyx Pharmaceuticals (Filer)
| Form ARS | |
04/24/2024
6:07 AM | Amylyx Pharmaceuticals (Filer)
| Form DEF 14A | |
04/18/2024
7:19 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:20 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:20 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:21 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:23 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:19 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
6:10 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
03/15/2024
3:31 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/15/2024
3:35 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
8:18 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:44 AM | Amylyx Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
| Form SC 13G | |
03/08/2024
6:10 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
5:44 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
5:13 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
5:20 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
5:22 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:22 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:08 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:36 PM | Amylyx Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
9:24 AM | Amylyx Pharmaceuticals (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A | |
02/14/2024
6:15 AM | Amylyx Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
01/29/2024
4:25 PM | Amylyx Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G | |
01/29/2024
3:38 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:50 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:04 PM | Amylyx Pharmaceuticals (Issuer)
Yeramian Patrick D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:10 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:11 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:11 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
3:37 PM | Amylyx Pharmaceuticals (Issuer)
Firestone Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
